Latest Capital Raising News

Syntara Limited has reported encouraging interim Phase 2 trial results for its lead drug candidate SNT-5505 in myelofibrosis, alongside a successful A$15 million capital raise to advance multiple clinical programs.

Metal Hawk Limited reports exceptional high-grade gold discoveries at its Leinster South Project, alongside a successful $2.5 million capital raise, setting the stage for imminent drilling activities.

DroneShield Limited reports a 6.3% increase in 2024 revenue to $57.5 million, underpinned by a doubling of SaaS sales and a robust $1.2 billion sales pipeline heading into 2025.

BOSS Energy Limited's December quarter cash flow report reveals a $7.9 million net cash outflow from operations and a slight reduction in cash reserves to $65.2 million, underscoring ongoing investment in exploration activities.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Horizon Minerals reported a $5.165 million cash outflow for Q4 2024 but bolstered its liquidity with a capital raising in January 2025, extending its runway amid ongoing exploration investments.

Horizon Minerals reports a $14 million placement and a proposed merger with Poseidon Nickel, alongside key production milestones including the first gold pour at Boorara and a prefeasibility study at Penny's Find.

Ramelius Resources delivered a robust December 2024 quarter with record underlying free cash flow of A$174.5 million and gold production of 85,311 ounces, maintaining full-year guidance while advancing key projects and expanding its management team.

29Metals delivered a solid December 2024 quarter, meeting production and cost targets while strengthening its balance sheet through a $180 million equity raising and senior debt refinancing. The company is poised to extend its Golden Grove mine life with the Gossan Valley investment.

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.

Terrain Minerals has reopened its strategic placement to raise an additional $150,000 at a premium price, attracting a specialist micro-cap fund and reinforcing confidence in its gallium and base metals projects.